VolitionRx Limited Current Liabilities
VolitionRx Limited (VNRX) had Current Liabilities of $13.49 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $13.49M.
- 2026-03-31: Liabilities, Current $13.57M.
- 2025-12-31: Liabilities, Current $12.23M.
- 2025-09-30: Liabilities, Current $11.42M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.49M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $13.57M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $12.23M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $11.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $9.24M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $8.27M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.79M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $30.28M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $30.98M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $31.49M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $8.94M 10-K · filed 2025-03-31 | $31.84M 10-K · filed 2024-03-25 |
| 2023-09-30 | $17.65M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $18.80M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $17.24M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $17.39M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $16.98M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $17.35M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $17.51M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $6.52M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $5.85M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.40M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $6.00M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $6.24M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $4.32M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $4.71M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $4.63M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.86M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $3.24M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.50M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $2.67M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.33M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $2.67M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.34M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $2.61M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.29M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $2.83M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.24M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $2.27M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.03M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $2.02M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.55M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.44M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.12M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $1.09M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.27M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $996.57K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $2.71M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $7.58M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $3.15M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $5.19M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $957.27K 10-K · filed 2015-03-18 | |
| 2013-09-30 | $585.41K 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $674.34K 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $945.92K 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $747.77K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $476.76K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $422.63K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $576.62K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $534.36K 10-K · filed 2013-04-01 | |
| 2010-12-31 | $1.45M 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |